These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 3309814

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R, Griggs D, Andrews JM.
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [Abstract] [Full Text] [Related]

  • 3. [Intraocular penetration of a new quinolone in humans: pefloxacin].
    Bron A, Talon D, Delbosc B, Estavoyer JM.
    Bull Soc Ophtalmol Fr; 1987 Nov; 87(11):1261-2, 1265-8. PubMed ID: 3482788
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
    Frydman AM, Le Roux Y, Lefebvre MA, Djebbar F, Fourtillan JB, Gaillot J.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intraperitoneal penetration of pefloxacin.
    Webberly JM, Donovan I, Wise R, Ashby J.
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):207-8. PubMed ID: 3134221
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Rickettsiaceae infections and fluoroquinolones].
    Bertrand A, Janbon F, Jonquet O, Reynes J.
    Pathol Biol (Paris); 1988 May; 36(5):493-5. PubMed ID: 3043346
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative bioavailability of two brands of norfloxacin.
    Seth SD, Beotra A, Seth S.
    J Assoc Physicians India; 1995 May; 43(5):324-6. PubMed ID: 9081960
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats.
    Delon A, Huguet F, Courtois P, Vierfond JM, Bouquet S, Couet W.
    J Pharmacol Exp Ther; 1997 Feb; 280(2):983-7. PubMed ID: 9023315
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.